Strides Pharma Science P/E Ratio

STAR • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
16.77
Moderate Valuation
Moderate - Fairly valued

Current Valuation Metrics

P/E Ratio 16.77
Current Price ₹964.40
EPS (TTM) ₹390.55
Exchange NSE

Valuation Signal

Signal Fairly Valued
Historical Avg 20.57
Historical Range 1.52 - 41.26
Percentile 60.0%

Sector Context

Sector Average 47.71
Sector Median 25.75
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹55.50
Sept 2025 ₹13.84
Mar 2025 ₹8.92

Key P/E Ratio Insights for Strides Pharma Science

  • Trading at discount to sector average PE of 47.71

P/E Ratio Historical Trend for Strides Pharma Science

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 12.69 55.5 ₹704.30 NSE Low
2024 1.52 383.99 ₹584.55 NSE Low
2019 12.96 32.14 ₹416.50 NSE Low
2017 41.26 23.14 ₹954.65 NSE High
2016 34.4 33.9 ₹1166.30 NSE High

Sector P/E Ratio Comparison

Comparing Strides Pharma Science with other companies in Healthcare sector
Sector Average
47.71
Sector Median
25.75
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low